# Martin Lefkowitz

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/martin-lefkowitz/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,682 |
| Field | Heart Failure Treatment and Management |
| h-index | 70 |
| i10-index | 140 |
| Last Known Institution | Novartis (United States) |
| OpenAlex ID | https://openalex.org/A5080343259 |
| Works | 236 |

## Researcher papers

- [Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure](https://scholariq.org/papers/angiotensin-neprilysin-inhibition-versus-enalapril-in-heart-failure/)
- [Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction](https://scholariq.org/papers/angiotensin-neprilysin-inhibition-in-heart-failure-with-preserved-ejection/)
- [Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure](https://scholariq.org/papers/angiotensin-receptor-neprilysin-inhibition-compared-with-enalapril-on-the-risk/)
- [Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure](https://scholariq.org/papers/sacubitril-valsartan-across-the-spectrum-of-ejection-fraction-in-heart-failure/)
- [Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure](https://scholariq.org/papers/renal-effects-and-associated-outcomes-during-angiotensin-neprilysin-inhibition/)
- [Developing Therapies for Heart Failure With Preserved Ejection Fraction](https://scholariq.org/papers/developing-therapies-for-heart-failure-with-preserved-ejection-fraction/)
- [Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure With Preserved Ejection Fraction](https://scholariq.org/papers/angiotensin-neprilysin-inhibition-and-renal-outcomes-in-heart-failure-with/)
- [Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/challenges-in-conducting-clinical-trials-in-nephrology-conclusions-from-a-kidney/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)

## Researcher university

- [Novartis (United States)](https://scholariq.org/institutions/novartis-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.